News | Artificial Intelligence | December 14, 2022

MedCognetics’ AI enabled breast cancer screening software, QmTRIAGE, has received FDA 510(k) clearance.

MedCognetics’ AI enabled breast cancer screening software, QmTRIAGE, has received FDA 510(k) clearance.

MedCognetics’ AI enabled breast cancer screening software, QmTRIAGE, has received FDA 510(k) clearance. Photo credit: MedCognetics, Inc. 


December 14, 2022 — Dallas, TX-based MedCognetics, Inc. announced it has received U.S Food and Drug Administration (FDA) 510(k) clearance for its AI enabled software for breast cancer screening, QmTRIAGE. The company provides an advanced AI software platform with the goal of reducing time and cost of imaging, and improving outcomes across diverse patient populations, according to a company statement. The platform integrates into radiology workflow and is also training its AI algorithm on a diverse global patient database to mitigate data biasing. MedCognetics has teamed up with the University of Texas at Dallas and University of Texas Southwestern Medical Center (UTSW) in Dallas, Texas to help achieve its goals. 

“The American Cancer Society has stated that in 2022 approximately 287,850 new cases of invasive breast cancer will be diagnosed in women,” said Debasish Nag, chief executive officer, MedCognetics, Inc. “To do so, MedCognetics has partnered with both University of Texas at Dallas and University of Texas Southwestern Medical Center (UTSW) to address these disparities. In addition, our software’s high detection accuracy enables reduced time for review by radiologists, another key component to improved outcomes. The FDA’s clearance is a very important first step for us as we work toward expanding to other realms of cancer,” Nag added.

“The use of AI in medicine has helped bridge many gaps in the detection and treatment of cancers,” said W. Phil Evans, M.D., FACR, Clinical Professor of Radiology at UT Southwestern Medical Center (UTSW), and Chief of its Breast Imaging Division. “We are working to leverage this technology to address data bias regarding breast health and imaging,” noted Evans.

UTSW, which has licensed intellectual property to MedCognetics and holds equity in the company, provided the deidentified clinical data (i.e., breast imaging cases). These assisted in the validation of MedCognetics unbiased AI algorithm. The company also teamed up with UT Dallas, which also holds an equity stake, by licensing intellectual property from its Quality of Life Technology Laboratory. In addition to tackling the trend of training on a dominant ethnic population base, the MedCognetics platform also reduces the amount of time a Radiologist needs to review a case; this is especially vital in underserved communities and areas of the world where medicine and diagnostic imaging are scarce.

According to the statement released by MedCognetics on its FDA clearance, QmTRIAGE provides an unbiased advanced imaging algorithm that leverages AI and Machine Learning (ML) to detect the earliest manifestations of cancer in all ethnicities. The digital health software platform can be deployed on customer premises, via the cloud or through the web – providing customers with one of the most accessible medical AI algorithms on the market.

For information: www.medcognetics.com


Related Content

News | Artificial Intelligence

November 28, 2023 — iCAD, Inc., a global medical technology leader in innovative cancer-detection solutions, and ...

Time November 28, 2023
arrow
News | Digital Radiography (DR)

November 28, 2023 — Canon Medical Components USA (CMCU) - Digital Radiography (DR), global leaders in advanced flat ...

Time November 28, 2023
arrow
News | Computed Tomography (CT)

November 28, 2023 — Smoking marijuana in combination with cigarettes may lead to increased damage of the lung’s air sacs ...

Time November 28, 2023
arrow
Feature | RSNA | Christine Book

November 28, 2023 — By early Monday morning, on the second day of RSNA 2023, there were significant news announcements ...

Time November 28, 2023
arrow
News | Artificial Intelligence

November 27, 2023 — Mass General Brigham and Annalise.ai today announced a collaboration to bring together their ...

Time November 27, 2023
arrow
News | RSNA

November 27, 2023 — The executive leadership teams from Canon Inc. and Cleveland Clinic gathered early on day two of the ...

Time November 27, 2023
arrow
News | Breast Imaging

November 27, 2023 — Barco announces introduction of the DL Precise AI software in addition to the current Intuitive ...

Time November 27, 2023
arrow
Feature | RSNA

November 27, 2023 — The collective anticipation of the radiology community was palpable from early morning through ...

Time November 27, 2023
arrow
News | Radiation Dose Management

November 27, 2023 — Qaelum NV, a leading provider of innovative healthcare solutions, and Philips, a global leader in ...

Time November 27, 2023
arrow
News | Digital Radiography (DR)

November 26, 2023 — Konica Minolta Healthcare Americas, Inc., announced today several new solutions in digital ...

Time November 26, 2023
arrow
Subscribe Now